Announcements

The latest Impact Factors have been released and are updated in our site!

Not a Current Subscriber?

Subscribe Now

5819 Journals

4824 Congresses

10600+ Unique Records

Frontiers in Drug Safety and Regulation

Electronic ISSN

2674-0869

Therapeutic Area

Clinical Pharmacology, Medicine, Pharmaceutical Sciences, Pharmaceutical Technology/Drug Technology, Pharmacoepidemiology, Pharmacovigilence, Public Health, Vaccines/Vaccinology

Readership

Academicians, Allied Health Professionals, Clinical Pharmacologists, Clinicians, Health Professionals, Medical Directors, Medical Practitioners, Medicinal Chemists, Patient Advocates, Patients, Pharmaco-Epidemiologists, Pharmacovigilence Specialists, Policy Makers, Public Health Professionals, Scientists, Vaccinologists

Scope

Frontiers in Drug Safety and Regulation is a Scopus-indexed multidisciplinary journal that aims to address potentially emerging issues concerning pharmacovigilance, with special emphasis on how the post-marketing surveillance drives informed regulatory decision process and vice-versa. Led by Field Chief Editor Prof Gianluca Trifirò (University of Verona, Italy), Frontiers in Drug Safety and Regulation publishes epidemiological, clinical and translational original articles, editorials and reviews across the fields of clinical pharmacology, pharmacovigilance, pharmacoepidemiology, drug policy, public health and regulatory science. Topics of interest include: Advanced methods in pharmacovigilance and pharmacoepidemiology; Cardiovascular drug safety; Maternal-fetal medicine; Respiratory drug safety; Rheumatic drug safety; Substance-based medical devices; Vaccine safety and regulation. Drug safety monitoring is an essential element for the effective and safe use of medicines and for high quality medical care and it is the process of detection, assessment, understanding and prevention of side effects, allowing an in-depth knowledge of the benefit-risk profile of conventional drugs and vaccines as well as Advanced Therapy Medicinal Products (ATMPs, e.g., gene therapy medicinal products, somatic cell therapy medicinal products, tissue engineered medicinal products, medicinal products for combined advanced therapies,), dietary supplements/nutraceuticals and medical devices. Regulatory science refers to the range of scientific disciplines aimed at assessing the quality, safety and efficacy/effectiveness of medicinal products and informing regulatory decision-making throughout the lifecycle of a medicine. It comprises basic and applied biomedical and social sciences and contributes to the development of regulatory standards and tools. In particular, the journal welcomes submissions which support and advance the UN’s Sustainable Development Goals (SDGs), notably SDG 3: ensure healthy lives and promote well-being for all at all ages. Collaboration between clinicians and basic scientists is strongly encouraged by the editors and papers issued from a collaborative strategy between the academic and the private industrial sectors are welcome. Frontiers’ journals require that manuscripts primarily comprising computational studies of public data, must include appropriate validation. Please refer to the Frontiers Standards for research methodology policy, for more information. Manuscripts not adhering to these standards will not be considered. Frontiers in Drug Safety and Regulation is committed to contributing to elevating regulatory sciences with a patient-oriented approach addressing emerging issues concerning drug safety while taking together clinician, regulatory, academic, patient as well as industry perspective. The journal aims to advance developments in the field of drug safety and regulation research by allowing unrestricted access to articles, and communicating scientific knowledge to researchers and the public alike, to enable the scientific breakthroughs of the future.

Sponsoring Association(s)

No associations affiliated with this journal

Publisher Name

Frontiers Media SA

To see more details about Frontiers in Drug Safety and Regulation, Subscribe Now!

Frequency Author Submission Guidelines

Testimonials

"PubsHub [Journals & Congresses] is an indispensable tool when trying to find the perfect home for a manuscript. It is an unbeatable aid when it comes to wise and efficient journal selection."
	– Kait G Editorial-Project Editor
"It’s useful for establishing publication timelines, communicating them to management and setting expectations accordingly"
	– Michael K. Medical Communications Leader
"…a gold mine of information for clinicians and scientists who are trying to determine where to publish their research."
	- Weill Cornell Medical Library

Journals ● Congresses ● Associations

Privacy Policy ● Terms of Service ● Glossary ● Contact Us